Jayex Technology Limited Share Price

Equities

JTL

AU0000155293

Advanced Medical Equipment & Technology

Delayed Australian S.E. 06:14:05 14/03/2024 am IST 5-day change 1st Jan Change
0.005 AUD -.--% Intraday chart for Jayex Technology Limited -.--% -44.44%

Financials

Sales 2021 3.84M 2.5M 209M Sales 2022 4.51M 2.94M 246M Capitalization 2.74M 1.79M 149M
Net income 2021 -3M -1.96M -163M Net income 2022 -7M -4.57M -381M EV / Sales 2021 2.37 x
Net Debt 2021 4.34M 2.83M 237M Net Debt 2022 5.16M 3.37M 281M EV / Sales 2022 1.75 x
P/E ratio 2021
-1.02 x
P/E ratio 2022
-0.38 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 25.23%
More Fundamentals * Assessed data
Dynamic Chart
3 months-44.44%
6 months-28.57%
Current year-44.44%
More quotes
Current year
0.01
Extreme 0.005
0.01
1 year
0.01
Extreme 0.005
0.01
3 years
0.00
Extreme 0.004
0.04
5 years
0.00
Extreme 0.004
0.08
10 years
0.00
Extreme 0.004
0.35
More quotes
Managers TitleAgeSince
Chief Executive Officer - 03/22/03
Corporate Secretary 51 19/15/19
Members of the board TitleAgeSince
Chairman - 04/06/04
Director/Board Member - 01/09/01
More insiders
Jayex Technology Limited is an Australia-based company engaged in the development and provision of healthcare industry service technologies, and the development of integrated dispensing automation systems for the pharmaceutical and healthcare sectors. The Company's segments include Australia and United Kingdom. Its products include Jayex Connect and Enlighten. Jayex Connect is a cloud-based patient engagement platform, which is made up of five modules, such as CONNECT, ARRIVE, DISPLAY, APPOINTUIT, CAMPAIGN AND SURVEY, each targeting at a specific aspect of patient management. Enlighten is a patient workflow platform, which is designed to enhance patients experience while providing friction-free check-in process for patients. Its platform capabilities include appointment booking, patient calling, patient check-in, through to health messaging, self-care monitoring, script management, remote terminal dispensing of pharmaceutical and/or medical cannabis products and telehealth solutions.
More about the company